Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...
During her visit to Ukraine, Austria's foreign minister responded to the FPO’s ongoing criticism in public media, asserting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback